330 related articles for article (PubMed ID: 32683826)
1. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].
Zhao DB; Zhang XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826
[TBL] [Abstract][Full Text] [Related]
2. ["See fine world" -copy experience and thinking of membrane anatomy in laparoscopic radical gastrectomy (D2+CME)].
Bi R; Wei YZ; Wang K
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):418-422. PubMed ID: 31104424
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
4. [Application of membrane anatomy in key technologies during gastric cancer surgery: guidance and compromise].
Shen J; Zhang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):648-652. PubMed ID: 32683824
[TBL] [Abstract][Full Text] [Related]
5. [Mesogastrium theory of D2 lymphadenectomy for advanced gastric cancer: cogitation and skills].
Yan WF; Wen DP; Zhang JC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):653-656. PubMed ID: 32683825
[TBL] [Abstract][Full Text] [Related]
6. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
7. [Infrapyloric lymph node dissection in gastric cancer radical surgery under the guidance of mesenteric anatomy theory].
Hu JK; Zhang WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):413-417. PubMed ID: 31104423
[TBL] [Abstract][Full Text] [Related]
8. [Practical membrane anatomy of en bloc mesogastrium excision in lymph node dissection of gastric cancer].
Zhang JP; Shen J; Dong XG; Ma X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):926-931. PubMed ID: 31630488
[TBL] [Abstract][Full Text] [Related]
9. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.
Brenner B; Shah MA; Karpeh MS; Gonen M; Brennan MF; Coit DG; Klimstra DS; Tang LH; Kelsen DP
Ann Oncol; 2006 Sep; 17(9):1404-11. PubMed ID: 16788003
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
Tai Q; Shao H; Liu Y; Li E; Zhao R
J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
[TBL] [Abstract][Full Text] [Related]
12. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
13. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
[TBL] [Abstract][Full Text] [Related]
14. [Laparoscopic gastrectomy combined with neoadjuvant chemotherapy for gastric cancer patients: from the view of the CLASS-03a trial].
Hu J; Zhang W; Chen X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):138-142. PubMed ID: 29492910
[TBL] [Abstract][Full Text] [Related]
15. Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancer.
Xie D; Yu C; Liu L; Osaiweran H; Gao C; Hu J; Gong J
Surg Endosc; 2016 Nov; 30(11):5138-5139. PubMed ID: 27005289
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
18. Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Kunisaki C; Makino H; Kimura J; Takagawa R; Kanazawa A; Ota M; Kosaka T; Ono HA; Akiyama H; Endo I
Oncology; 2015; 88(5):281-8. PubMed ID: 25591954
[TBL] [Abstract][Full Text] [Related]
19. [Replication of 3D laparoscopic membrane anatomic radical gastrectomy for gastric cancer].
Wang Q; Yang HX; Zhang L; Wang HB; Yan ZQ; Xie HT; Chen JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):423-426. PubMed ID: 31104425
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
